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ABSTRACT
Objective: To evaluate the effect of inﬂuenza vaccination on
the reduction of the risk of outpatient visits for upper respi-
ratory infection (URI) among the elderly in Taiwan.
Methods: The data for this observational study, consisting
of 1729 people aged 65 years or older, were drawn from Tai-
wan’s 2001 National Health Interview Survey. This survey
data was then linked with National Health Insurance claim
data for December 2001 to November 2002. Survival anal-
ysis of Cox proportional hazards model was performed to
examine the risk of URI outpatient visits in elderly people
vaccinated with the inﬂuenza vaccine and those not vacci-
nated during a year-long study period since the inﬂuenza sea-
son began. To adjust for potential self-selection bias, we used
propensity score method to categorize individuals into two
groups, based on the predicted probability of being vacci-
nated from a logistic regression of spatial random effect. Pro-
pensity score group 1 (PSG 1) were those with a predicted
probability of being vaccinated lower than 0.5, and PSG 2
were those with a predicted probability of being vaccinated
of 0.5 or higher.
Results: The overall vaccination rate was 50%. Logistic
regression showed the probability of being vaccinated was
related to the number of outpatient visits for URI before the
inﬂuenza season began (odds ratio (OR) 1.07; 95% conﬁ-
dence interval (CI) 1.04–1.10). Our ﬁrst survival analysis
showed that being vaccinated signiﬁcantly reduced the risk of
URI outpatient visits in PSG 2 during the 1-year study period
(hazard ratio 0.89; 95% CI 0.81–0.97). Separate survival
analysis showed that being vaccinated reduced the risk of
URI outpatient visits for both PSG groups during the ﬁrst
3 months of the study period.
Conclusion: Being vaccinated could reduce the risk of out-
patient visits for URI among the elderly during the inﬂuenza
season.
Keywords: inﬂuenza vaccine, survival analysis, Taiwan,
upper respiratory infection.
Introduction
Studies have proved that the inﬂuenza vaccine can
effectively reduce inﬂuenza-related hospitalizations
and mortality [1–3]; therefore, many Western coun-
tries encourage the elderly and other vulnerable patient
groups to receive inﬂuenza vaccinations [4]. In 1998,
the Taiwan government implemented a policy allowing
elderly people at high risk of contracting inﬂuenza to
be vaccinated at no charge. In 2001, this vaccination
policy was expanded to cover all elderly regardless of
risk status. Later, because of the substantial economic
loss that Taiwan incurred during the 2003 SARS epi-
demic, the inﬂuenza vaccination was made available to
all people aged 55 years and older free of charge, mak-
ing Taiwan’s inﬂuenza vaccination program one of the
most generous in the world [5]. As understood, how-
ever, the effectiveness of the inﬂuenza vaccine has been
reported to depend on the similarity between the virus
strains in the vaccine and those in circulation in the
population, age, immunocompetence of a vaccine
recipient, chronic conditions of a vaccine recipient,
and the timing of the vaccination [6]. Thus, although
the government was making public health vaccination
more freely available, a fundamental policy question
was raised about how effective the inﬂuenza vaccina-
tion was at preventing clinical cases of inﬂuenza.
The effectiveness of inﬂuenza vaccination in re-
ducing inﬂuenza-related illnesses, hospitalization, and
death is well established in persons aged 65 years or
older [3,7–17], and it is suggested that all people of
this age be immunized annually [3,18,19]. On the
other hand, studies in the United States have shown the
cost-effectiveness or cost-beneﬁts of the inﬂuenza vac-
cine for people with different levels of health risk
[3,8,10,11,20,21]. Cost-beneﬁt and cost-effectiveness
studies from other countries, including Canada [22],
England and Wales, France, Germany [23], The Neth-
erlands [24], New Zealand [25], and some local areas
in Taiwan [26], also suggest that vaccinating the
elderly is cost-effective and frequently cost saving,
although a few have not [27,28].
Results from economic studies on inﬂuenza vacci-
nation, however, often have certain limitations and at
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times have methodological problems. Indeed, the most
preferable study design for this issue would be a ran-
domized controlled trial. Nevertheless, because the
incidence rate of inﬂuenza-related severe complica-
tions is low, clinical trials often need large sample size
and thus are extremely expensive. On the other hand,
there have also been ethical concerns in clinical trials
with regard to offering or not offering vaccinations to
vulnerable people [29]. These selection and exclusion
criteria limit the generalization of clinical trial results
to the general population. As a result, nonexperimen-
tal studies were more often seen than clinical trials.
Extreme caution should be used when interpreting
the conclusions of nonexperimental vaccination stud-
ies. Experimental and nonexperimental designs differ
mainly in the absence of random allocation of inter-
vention, which causes the problem of self-selection and
biased estimates. In nonexperimental inﬂuenza vaccine
studies, vaccine groups typically consist of patients
with more severe diseases or people perceived to be at
higher risk than nonvaccinated groups (self-selection)
[30]. Those contraindicated for intervention are often
allocated to the control group only. The effects of such
perceptions of risk or health needs on defensive behav-
ior have been identiﬁed in studies on HIV infection
[31] and measles infections [32]. The selection of inter-
vention (vaccination) is confounded by clinical and
nonclinical patient factors, resulting in invalid infer-
ences about the effectiveness of inﬂuenza vaccination.
Having a poorer health status has been positively asso-
ciated with a greater likelihood of being vaccinated
[30,33], which might indicate self-selection by the
patient or possibly an assessment of the patient’s
health by the physician [34]. Thus, ignoring selection
bias would possibly lead to the underestimation of the
effect of inﬂuenza vaccine for those vaccinated individ-
uals, because they are often in poorer health and are
more likely to get sick than those unvaccinated.
In Taiwan, the effectiveness of inﬂuenza vaccination
in the elderly has been analyzed mainly by three studies
[26,35,36], all focusing on mortality and hospitaliza-
tion. One reported national statistics on health out-
comes [36]; the other two analyzed secondary data of
hospitalization and mortality, collected for a speciﬁc
county or city [26,35]. These studies were subject to
the limitations of generalization to nationwide elderly
and selection bias of being vaccinated [35], which
might bias the evaluation of the effectiveness of the
inﬂuenza vaccination. Given these ﬁndings, evidence
on minor cases is so far not available whether the inﬂu-
enza vaccine could not only reduce death and hospi-
talization for severe cases but also reduce general
inﬂuenza and upper respiratory infections (URI) in
Taiwan, suggesting that it can limit the spread of an
epidemic.
In the present observational study, we examined
whether being vaccinated reduced the risk of URI,
measured by the occurrence of outpatient visits,
among the elderly in Taiwan. Our data were drawn
from a national health interview survey carried out
between August 2001 and January 2002 and National
Health Insurance (NHI) outpatient records for elderly
aged 65 years or older for the year 2002. We used a
propensity scoring method to reassign individuals to
different groups (with a similar probability of receiving
an inﬂuenza vaccine) and included the groups into sur-
vival analysis to compare the risk of URI outpatient
visits in elderly people vaccinated with the inﬂuenza
vaccine just before the beginning of a year in which an
inﬂuenza epidemic occurred and in those who were not
vaccinated at that time.
Methods
To adjust for the potential bias caused by self-
selection, we used a propensity scoring method [37]
based on logistic regression of spatial random effect to
categorize patients into propensity groups. Propensity
score group 1 (PSG 1) were those with a predicted
probability of being vaccinated lower than 0.5, and
PSG 2 group were those with a predicted probability
of being vaccinated of 0.5 or higher. With the two PSG
groups, we used survival analysis to examine the effect
of vaccination on 1) the occurrence of outpatient visits
for URI, and 2) the occurrence of either hospitalization
for lung-related diseases or outpatient visits for URI.
Data Sources
Data were drawn from two sources: the 2001 National
Health Interview Survey (NHIS) and the National
Health Insurance outpatient records of interviewees
who consented to the linking of the information from
the two sources. The data from the 2001 NHIS were
collected between August 2001 and January 2002. The
survey had two parts: a representative sample of
Taiwan’s population of 23 million people and an
oversampling of residents in the mountain regions and
Taiwan’s various offshore islands. The survey used a
stratiﬁed multistage sampling design with the proba-
bility of selection proportional to the population size.
The primary sample units consisted of 368 townships
throughout Taiwan and outlying islands, 12 districts
within the Municipality of Taipei, and 11 districts
within the Municipality of Kaohsiung. Each primary
sample unit was segmented according to level of
urbanization, deﬁned by socioeconomic and demo-
graphic characteristics. The segment clusters were then
chosen by area to serve as the basic sampling that the
survey would target. All family members of each sam-
pled household were included in our sample. A partic-
ipant’s survey data were linked with his or her NHI
data by personal identiﬁcation number only if he or
she signed an informed consent form allowing the link-
ing of the information from both sources.
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We selected 23,473 surveyed individuals (5798
households), representative of Taiwan’s general popu-
lation. From those 23,473 individuals, we selected
2110 elderly persons aged 65 years or older. We
excluded 381 interviewees who did not sign the in-
formed consent allowing their survey data and NHI
data to be linked, leaving us with a total of 1729 eld-
erly persons. Table 1 compares the differences between
those who did not sign the informed consent with
those who did. Those who did not sign the informed
consent were more likely to be female (P < 0.05), illit-
erate (P < 0.0038), uncoupled (P < 0.005), high-risk,
or have fewer family members with URI during the
study period.
Inﬂuenza Season
According to the US Centers for Disease Control and
Prevention (CDC), the worldwide inﬂuenza season
was from October 2001 to May 2002 [38]. According
to the criteria used in the literature [35], the inﬂuenza
season in Taiwan in our study was deﬁned based on
active inﬂuenza-surveillance data from the CDC in
Taiwan [39,40]. The morbidity of inﬂuenza started to
rise from the beginning of December 2001, reached its
peak in January 2002, and reached a plateau by the
end of March 2002. Therefore, this study deﬁned the
period between December 1, 2001 and March 31,
2002 to be the inﬂuenza-epidemic season of 2002, and
Table 1 Characteristics of Taiwanese elderly who gave informed consent for linking National Health Insurance data to 2001 National
Health Interview Survey and those who did not
Total sample
(n = 2110)
Signed informed 
consent
(n = 1729)
Did not sign
informed consent 
(n = 381) 
P-value*n % n % n %
I. Demographic factors
Age group (years)
65–70 860 40.76 723 41.82 137 35.96 0.1232*
71–75 599 28.39 478 27.65 121 31.76
76–80 358 16.97 283 16.37 75 19.69
>80 292 13.84 244 14.11 48 12.60
Missing (years; mean/SD) 1 0.05 1 0.06 0 0.00
73.01 ± 6.05 72.93 ± 6.12 73.35 ± 5.69 0.2168‡
Sex
Male 1081 51.23 906 52.40 175 45.93 0.0222*
Female 1029 48.77 823 47.60 206 54.07
Educational level
Illiterate 706 33.46 549 31.75 157 41.21 0.0038*
Elementary school or literate 888 42.09 738 42.68 150 39.37
Junior high school 194 9.19 161 9.31 33 8.66
Senior high school 169 8.01 143 8.27 26 6.82
College 149 7.06 134 7.75 15 3.94
Missing 4 0.19 4 0.23 0 0.00
Marital status
Coupled 1386 65.69 1162 67.21 224 58.79 0.0025*
Uncoupled 720 34.12 565 32.68 155 40.68
Monthly household income (NT$)
<30,000 887 42.04 718 41.53 169 44.36 0.6133*
30,001–50,000 409 19.38 344 19.90 65 17.06
50,001–70,000 309 14.64 256 14.81 53 13.91
70,001–100,000 224 10.62 179 10.35 45 11.81
≥100,001 254 12.04 208 12.03 46 12.07
Missing 27 1.28 24 1.39 3 0.79
Employment status
Yes 230 10.90 199 11.51 31 8.14 0.0558*
No 1880 89.10 1530 88.49 350 91.86
Subsidy
Yes 1046 49.57 866 50.09 180 47.24 0.0593*
No 1061 50.28 862 49.86 199 52.23
Missing 3 0.14 1 0.06 2 0.52
II. Health status
High-risk group
Yes 1208 57.25 985 56.97 223 58.53 0.0117*
No 858 40.66 715 41.35 143 37.53
Missing 44 2.09 29 1.68 15 3.94
URI OPD# in 6 months† (mean/SD) 2.19 ± 4.15 2.19 ± 4.15 – 0.0247‡
Number of sick family members (mean/SD)
(who signed informed consent)
2.28 ± 1.31 2.31 ± 1.32 2.14 ± 1.29
*P-value for chi-square statistics.
†Number of outpatient visits for upper respiratory infection (URI) during the 6 months before the vaccination date.
‡P-value for t-test statistics.
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collected 1-year NHI claim data since December 1,
2001 for research purposes.
Variable Deﬁnition
To evaluate the effect of the inﬂuenza vaccination on
ﬂu-related clinical events, we measured the clinical
events in two ways: 1) the ﬁrst time the patient went to
the outpatient clinic for URI, and 2) the ﬁrst time the
patient went to an outpatient clinic or was hospitalized
for a lung-related disease.
1. Outpatient visits for URI. In 2002, the inﬂuenza
epidemic season lasted from December 2001 to
March 2002. The ﬂu vaccination was provided
free of charge from October 1, 2001 to March 31,
2002. Our 1-year observation period started from
the beginning of the inﬂuenza-epidemic season
on December 1, 2001 and continued through
November 30, 2002. One incidence of URI,
including inﬂuenza, was deﬁned when a patient
made an outpatient visit during the study period
with a diagnosis of a URI (International Classiﬁ-
cation of Disease, Ninth Revision, Clinical Mod-
iﬁcation [ICD9CM] = 460∼466, 487). Patients
without an outpatient record of URI were coded
as censored and assigned a 1-year survival time.
Seven of our patients received inﬂuenza vaccina-
tions after the inﬂuenza season had begun
(December 1, 2001), and were assigned to the
unvaccinated group between December 1, 2001
and their vaccination date. Once vaccinated, they
were reassigned to a new-case group.
2. Hospitalization for lung-related diseases or outpa-
tient visits for URI. During the same observation
period, we selected inpatient data with diagnoses
of inﬂuenza, pneumonia, and lung-related disease,
as deﬁned previously [41], as ﬂu-related clinical
cases. To combine these data with the outpatient
visits for URI, we selected the earliest clinical event
occurring during the observation period. That is,
if the patient had been hospitalized before any
outpatient visit, the time of hospitalization was
selected as time that a ﬂu-related clinical event
occurred; otherwise, the outpatient visit date was
identiﬁed as the ﬁrst ﬂu-related clinical event.
Vaccination variable and propensity score group
(PSG). The vaccination date was deﬁned as the date
recorded on the NHI outpatient claim. If patients
received a vaccination during the period that the vac-
cine was being offered free of charge, they were
assigned the dummy variable VCC of 1; if they did not
receive this vaccination during this period, they were
assigned the dummy variable 0. In assigning the PSG,
we used logistic regression to predict the probability of
being vaccinated (see Statistical Analysis). Patients
who had a predicted probability of being vaccinated
lower than 0.5 were assigned to PSG 1; those with a
probability of 0.5 or higher, to PSG 2.
In the logistic regression for propensity score, we
used a continuous variable of OPD_URI6, the number
of outpatient visits for URI during the 6 months before
the vaccination date. Patients who were not vaccinated
were assigned a number of OPD_URI6, based on the
accumulated number of outpatient visits for URI
before the ﬁrst day free vaccination was offered. In our
evaluation of the effect of vaccination on outpatient
visits for URI, we included a variable indicating risk of
exposure to URI. To do this, we used NHI claim data
for each of sample patient’s household members to
count the number of members who had visited an out-
patient clinic for URI during the study period. This
variable of EXPOSURE to URI was measured as the
number of family members with URI during the study
period. The other independent variables included age
in years (AGE); a dummy variable for SEX (1 for male
and 0 for female); ﬁve educational levels (EDUCA-
TION with reference group being illiterate); a dummy
variable for being coupled (MARRIED = 1 for being
coupled and 0 uncoupled); a dummy variable for
employment status (EMPLOYMENT) (1 being
employed and 0 unemployed); a dummy variable for
whether one belonged to a high-risk group (HIGH-
RISK) (1 as self-reported existing heart disease, lung
disease, diabetes, stroke, renal disease, catastrophic ill-
ness informed by the health professions; 0 for no indi-
cation of these risks); monthly household income
(NT$); and whether the household was receiving gov-
ernment welfare subsidy.
Statistical Analysis
Propensity score method. We used the propensity
score model as an analytical adjustment strategy to
measure the effect of inﬂuenza vaccination on reducing
outpatient visits for URI. The propensity score method
attempts to replicate an experimental design by com-
paring the outpatient visits for otherwise very similar
individuals. Individuals were aligned based on their
predicted probability of being vaccinated, and vacci-
nated individuals were matched with nonusers with a
similar probability of being vaccinated. This matching
process balanced the two groups on the observed fac-
tors that affect being vaccinated.
Previous studies have associated being vaccinated
with insurance reimbursement program [42], time cost
[30], and out-of-pocket costs [43,44]. Concerns about
possible side effects and disbelief in the efﬁcacy of vac-
cine have been among the main reasons for individuals
not to take advantage of inﬂuenza vaccinations
[45,46]. Other reasons for not being vaccinated are
lack of physician recommendation [34] and disap-
pointing overall immunization rates [3,42,46]. In addi-
tion to these factors, defensive behavior–perceptions of
risk or health needs has been found to be signiﬁcantly
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associated with the decision to receive a vaccination
[30–32].
In this study, for each individual j in the region i, we
used a logistic regression with spatial random-effect to
estimate the probability of being vaccinated as a func-
tion of  age,  sex,  education,  being  married,  being  in
a high-risk group, employment status, income level,
receiving subsidy, and outpatient visit 6 months before
receiving a vaccination (OPD_URI6).
where Pr(VCCij = 1) is the probability of the jth indi-
vidual’s being vaccinated in the region i, and bi is the
spatial random effects for adjusting the variation in the
space. Those random effects are often assumed to fol-
low a normal distribution with zero mean and covar-
iance matrix D.
From this logistic regression, we predicted the
probability  of  receiving  a  vaccination  based  on
each individual’s observed variables. This prediction
is called the propensity score, e(x), estimated by
e(x) = Pr(VCCij = 1). Patients who had a predicted
probability of receiving a vaccination lower than 0.5
were assigned to PSG 1; those with a probability of 0.5
or higher, to PSG 2. This PSG was included in the sur-
vival analysis.
Survival analysis of URI. A Cox proportional haz-
ards model was used to evaluate the association
between receiving a vaccination and occurrence of
URI. In the Cox proportional hazards model, the indi-
vidual’s hazard function is proportional to those of the
others. For the purposes of this study, we used three
models of survival analysis:
Model 1. The Cox proportional hazards model was
ﬁtted for total study sample:
The hazard function is
where t denotes survival time, h0(t) denotes the base-
line hazard function, (x1,x2, . . . ,xp) denotes the cov-
ariates, and (α1,α2, . . . ,αp) denotes the coefﬁcients of
covariates.
Model 2. The Cox proportional hazards model
adjusted by propensity score:
Give propensity score PSG, the hazard function is
log
Pr
Pr
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Model 3. The stratiﬁed Cox proportional hazards
model was adjusted by PSG. The common assumption
in models 1 and 2 was that the underlying hazard func-
tion h0(t) was the same in the vaccinated and unvacci-
nated group in time t. This assumption is relaxed in the
stratiﬁed Cox proportional hazards model, in which
the underlying hazard function is different for the two
groups. The regression coefﬁcients, however, are the
same for all groups. Given a propensity score PSG, the
hazard function is
for i = 1,2 denotes the vaccinated and unvaccinated
group, respectively.
Results
Table 2 compares data on those who were vaccinated
(n = 867) with those who were not (n = 862). The
unvaccinated group had a higher proportion of
patients more than 80 years old (16.71% vs. 11.53%),
illiterate patients (34.69% vs. 28.84%), and uncou-
pled patients (37.24% vs. 28.14%) than the vacci-
nated group. A higher percentage of vaccinated elderly
people were receiving governmental welfare subsidies
than the unvaccinated (53.29% vs. 46.87%). The
unvaccinated elderly had fewer outpatient visits for
URI (1.86, SD 3.86) in the 6 months before the study
period than the vaccinated group (2.53, SD 4.41).
Without any adjustment, the unvaccinated group had
a higher probability of having URI outpatient visits
(32.25% vs. 23.76%, P < 0.0001) and hospitalization
for lung-related diseases (6.42% vs. 3.11%,
P < 0.0036) than the vaccinated group. Among those
who had URI outpatient visits, the unvaccinated group
had fewer number visits (2.65 vs. 2.81, P < 0.05) than
the vaccinated group, but their ﬁrst-time URI outpa-
tient visit occurred nearly 50 days earlier than the vac-
cinated group (150 days vs. 201 days, P < 0.0001).
The results of random-effect logistic regression on
receiving an inﬂuenza vaccine show that visiting an
outpatient clinic for URI before the study period is
positively associated with the likelihood of receiving
an inﬂuenza vaccination (odds ratio (OR) 1.07; 95%
conﬁdence interval (CI) 1.04–1.10) (Table 3). Com-
pared with the illiterate patients, patients who were lit-
erate or had elementary-level education (OR 1.19;
95% CI 1.04–1.37) and junior high-school graduate-
level education (OR 1.17; 95% CI 1.03–1.32) were
more likely to receive a ﬂu vaccination. Uncoupled eld-
erly patients were less likely to receive an inﬂuenza
vaccination than coupled patients (OR 0.82; 95% CI
0.72–0.92). Receiving welfare subsidies from the gov-
ernment was positively associated with receiving an
inﬂuenza vaccination (OR 1.26; 95% CI 1.01–1.58).
Adding spatial random effect into logistic regression
h t x PSG h t PSG xi i j j
j
p
, exp( ) = ( ) ÊË
ˆ
¯=
Â0
1
a
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increased the pseudo R2 from 0.0224 to 0.0122. We
classiﬁed the patients with a predicted probability of
receiving an inﬂuenza vaccination lower than 0.5 into
PSG 1 and those with probability of 0.5 or higher into
PSG 2. Sixty percent of the elderly were in PSG 1, with
a vaccination rate of 42.9%; 40% of the elderly were
in PSG 2, with a vaccination rate of 62.9%.
Table 4 shows the survival analysis results on URI
outpatient visits of model 1 (total sample) and
model 2 (stratiﬁed by PSG group). The same analy-
sis was repeated once, this time including inpatients
with hospitalization event in outcome measurement.
The assumption of the Cox proportional hazards
model, which was one’s hazard was proportional to
another, was tested, and found to be a reasonable
assumption (all P-values greater than 0.05). On the
other hand, analysis of residuals showed that the
residuals were distributed around 0, between −3 and
Table 2 Characteristics of vaccinated and unvaccinated Taiwanese elderly, 2002
Total sample
(n = 1729)
Vaccinated
(n = 867)
Unvaccinated 
(n = 862) 
P-value*n % n % n %
I. Demographic factors
Age group (years)
65–70 723 41.82 357 41.18 366 42.46 0.0036‡
71–75 478 27.65 267 30.80 211 24.48
76–80 283 16.37 143 16.49 140 16.24
>80 244 14.11 100 11.53 144 16.71
Missing (years; mean/SD) 1 0.06 0 0.00 1 0.12
72.93 ± 6.12 72.66 ± 5.73 73.20 ± 6.48 0.0706*
Sex
Male 906 52.40 458 52.83 448 51.97 0.7223*
Female 823 47.60 409 47.17 414 48.03
Educational level
Illiterate 549 31.75 250 28.84 299 34.69 0.0938*
Elementary school or literate 738 42.68 384 44.29 354 41.07
Junior high school 161 9.31 91 10.50 70 8.12
Senior high school 143 8.27 73 8.42 70 8.12
College 134 7.75 68 7.84 66 7.66
Missing 4 0.23 1 0.12 3 0.35
Marital status
Coupled 1162 67.21 623 71.86 539 62.53 0.0001*
Uncoupled 565 32.68 244 28.14 321 37.24
Missing 2 0.11 0 0.00 2 0.23
Monthly household income (NT$)
<30,000 718 41.53 381 43.94 337 39.10 0.2492*
30,001–50,000 344 19.90 161 18.57 183 21.23
50,001–70,000 256 14.81 126 14.53 130 15.08
70,001–100,000 179 10.35 84 9.69 95 11.02
≥100,001 208 12.03 100 11.53 108 12.53
Missing 24 1.39 15 1.73 9 1.04
Employment status
Yes 199 11.51 99 11.42 100 11.60 0.9055*
No 1530 88.49 768 88.58 762 88.40
Subsidy
Yes 866 50.09 462 53.29 404 46.87 0.0161*
No 862 49.86 404 46.60 458 53.13
Missing 1 0.06 1 0.12 0 0.00
II. Health status
High-risk group
Yes 985 56.97 504 58.13 481 55.80 0.2137*
No 715 41.35 345 39.79 370 42.92
Missing 29 1.68 18 2.08 11 1.28
URI OPD# in prior 6 months† (mean/SD) 2.19 ± 4.15 2.53 ± 4.41 1.86 ± 3.86 0.0010‡
Number of sick family members (mean/SD) 
(who signed informed consent)
2.31 ± 1.32 2.32 ± 1.34 2.30 ± 1.29 0.8243‡
III. Health-care utilization
Outpatient visit during observational period
Yes 484 27.99 206 23.76 278 32.25 0.0001*
No 1245 72.01 661 76.24 584 67.75
Hospitalization visit during observation period
Yes 79 4.57 27 3.11 52 6.42 0.0036*
No 1650 95.43 840 96.89 810 93.97
Average number of outpatient visits 2.73 ± 1.68 2.81 ± 1.67 2.65 ± 1.96 0.0491‡
Average time until the ﬁrst visit for URI 171.63 ± 26.69 201.29 ± 12.91 150.18 ± 3.04 0.0000‡
*P-value for chi-square statistics.
†Number of outpatient visits for upper respiratory infection (URI) during the 6 months before the vaccination date.
‡P-value for t-test statistics.
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3 with no particular pattern, which indicated the
model.
Model 1, the pooled model on total elderly, showed
that receiving a vaccination signiﬁcantly reduced the
risk of URI outpatient visits (adjusted hazard ratio
(HR) 0.93; 95% CI 0.87–0.99). The elderly in the
high-risk group were indeed at a signiﬁcantly higher
risk of URI (HR 1.13; 95% CI 1.07–1.19) than the eld-
erly who were not. The number of family members
with NHI outpatient claims for visits for URI was
not associated with risk of URI (HR 1.02; 95% CI
0.97–1.08).
In model 2, the survival analysis of the Cox pro-
portional hazards model was carried out, stratiﬁed by
propensity groups. In PSG 1, receiving a vaccination
did not reduce the risk of URI (HR 0.91; 95% CI 0.81–
1.01). The patients in the high-risk group had a signif-
icantly higher risk of URI (HR 1.18; 95% CI 1.08–
1.28) than elderly patients who were not. Having more
family members with URI during the study period did
not increase the risk of URI (HR 1.05; 95% CI 0.96–
1.14). In PSG 2 (0.5 or higher), receiving a vaccination
did signiﬁcantly reduce the risk of URI outpatient visits
(HR 0.89; 95% CI 0.81–0.97). In that same group,
uncoupled elderly patients had a higher risk of URI
than coupled patients (HR 1.10; 95% CI 1.00–1.21).
As was found for PSG 1, the number of family mem-
bers with URI in PSG 2 with URI did not inﬂuence the
risk of URI (HR 1.00; 95% CI 0.92–1.07).
The results of model 3, the stratiﬁed Cox-propor-
tion hazards model, are not shown in Table 4, but
were plotted in two graphs in Figure 1, the ﬁrst graph
for propensity scores of less than 0.5 (PSG 1) and the
second for propensity scores PSG 2. The survival
curves with 95% CI lines in each graph show the ﬁrst
outpatient visits for URI in 365 days from the begin-
ning of the inﬂuenza season. The vaccinated group was
represented by a solid line and the unvaccinated group
by a dash line. Although results in Table 4 show that
vaccine did not have a signiﬁcant effect on reducing
Table 3 The propensity score model of being vaccinated: logis-
tic regression of spatial random effect
OR 95% CI
URI OPD# in prior 6 months* (mean/SD) 1.07 1.04–1.10
Sex
Reference: male
Female 1.12 0.99–1.26
Age (years) 0.99 0.97–1.01
Educational level
Reference: illiterate
Elementary school or literate 1.19 1.04–1.37
Junior high school 1.17 1.03–1.32
Senior high school 1.04 0.94–1.14
College 1.04 0.96–1.13
Marital status
Reference: coupled
Uncoupled 0.82 0.72–0.92
High-risk group
Reference: no
Yes 1.06 0.95–1.17
Employment status
Reference: no
Yes 0.96 0.81–1.13
Monthly household income (NT$)
Reference: <30,000
30,001–50,000 0.89 0.77–1.02
50,001–70,000 1.01 0.91–1.11
70,001–10,0000 1.00 0.91–1.08
≥100,001 0.99 0.93–1.06
Subsidy
Reference: no
Yes 1.26 1.01–1.58
*Number of outpatient visits for upper respiratory infection (URI) during the
6 months before the vaccination date.
The Hosmer–Lemeshow goodness-of-ﬁt test = 6.03; P-value = 0.64.
CI, conﬁdence interval; OR, odds ratio.
Figure 1 Survival analysis of upper respiratory
infection in the elderly in Taiwan.
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risk of URI outpatient visits in PSG 1, the whole year,
results drawn from the stratiﬁed Cox proportional
hazards model showed that, for both PSG, receiving a
vaccination signiﬁcantly reduced the occurrence of
URI outpatient visits in the ﬁrst 3 months of the inﬂu-
enza epidemic. In addition, the effect of the vaccine
was stronger in PSG 2.
Conclusion and Discussion
Inﬂuenza epidemics of varying severity occur almost
yearly and have a signiﬁcant impact on the health of
people and medical costs. Although Taiwan’s govern-
ment is making public health vaccination more freely
available, interest groups in the ﬁeld are raising fun-
damental policy questions about how effective inﬂu-
enza vaccination is at preventing clinical cases of
inﬂuenza. Our observational study attempts to answer
this question. To make up for the limitation found in
general nonexperimental studies, we linked unique
data sets: 1) NHIS to obtain detailed demographic
data, and 2) NHI claim data to identify the status of
vaccination and to retrieve records of outpatient visits
made by the subjects and their family members. We
used survival analysis to analyze the ﬁrst outpatient
visits for URI with analytical adjustment of the pro-
pensity score method to adjust potential selection bias,
which was often ignored in nonexperimental studies.
We found the elderly in Taiwan to have a vaccina-
tion rate of 50% and the overall probability that an
elderly patient would visit an outpatient clinic for URI
to be 27.99%. Using data on occurrences of outpatient
visits for URI, our survival analysis showed that being
vaccinated signiﬁcantly reduced the risk of URI by
nearly 7% in the elderly in Taiwan. The effect was
more obvious (11%) among individuals identiﬁed as
being more likely to receive a vaccination. The effect of
the vaccine was even more signiﬁcant during the ﬁrst
3 months of the inﬂuenza season than in the rest of the
study period. The results did not vary much when we
incorporated the events of hospitalization into our
analysis.
Our study design on survival analysis on total sam-
ple and on two PSG provides some valuable and
detailed information. First, the vaccine effect on PSG 1
(lower probability of being vaccinated) group was not
signiﬁcant. This highlights the importance of the pro-
pensity score method. Without stratifying the analysis
into two PSG, it would be very easy to believe that vac-
cination had the same effect on all individuals. Second,
adding Figure 1 drawn from separate survival analyses
showed that the effect of the vaccine was more
signiﬁcant, even in PSG 1, during the ﬁrst 3 months
rather than the whole year. In addition, the graph
showed that the vaccine effect on PSG 2 was larger
than its effect on PSG 1. Nonetheless, we admit that
further analysis should examine whether inﬂuenza vac-
cine not only postpones the occurrence of URI (limit-
ing the speed of epidemic) but also reduces the
frequency of URI visits (the scope of the epidemic).
Before examining that, we cannot conclude that Tai-
wan’s the vaccination program effectively reduced
overall outpatient visits for URI in the elderly.
Several factors should be taken into account when
drawing inferences from our study. First, nearly 18%
of the elderly people who were interviewed did not
sign the informed consent allowing us to link survey
data with NHI data. Those who declined to give
consent were more likely to be female, illiterate, and
uncoupled. Being uncoupled was signiﬁcantly associ-
ated with a higher probability of not being vaccinated.
Being uncoupled was also positively associated with a
higher risk of URI. Thus, we suspect that by excluding
these individuals our results may have underestimated
the inﬂuenza vaccine effect.
Second, strong presumptions were made in measur-
ing the occurrence of URI. In our study, we used the
secondary data of outpatient visits for URI as the
proxy of occurrence of URI, which was based on
strong presumptions: 1) people usually go to outpa-
tient care when they have a cold or ﬂu; 2) people with
ﬂu and cold have the same utilization pattern of health
care; and 3) the diagnosis code at outpatient visits cor-
rectly reﬂects the true clinical condition. There exists
no published evidence to verify the validity of the claim
data and its relationship with clinical condition. The
answer to the survey question of whether a patient
would choose to visit a physician of Western medicine
when he or she feels ill on the NHIS provided us with
some helpful information: 76.56% of the elderly
reported they would choose to visit the physician. An
unpublished analysis of the NHIS on the consistency
between the self-report outpatient visits and NHI out-
patient claim data showed that the kappa value was
0.64 and the agreement level between the claim data
and whether the interviewee ever visited the physician
as well as the number of visits in the past 1 month was
67.5%. Nevertheless, three strong presumptions could
have possibly biased our measure on clinical condition
of URI.
Third, although we used propensity score as ana-
lytical adjustment for potential selection bias of being
vaccinated on outpatient visit, the difference of haz-
ards ratio was small. The reader should bear in mind
that propensity score is a method of reconstructing,
after the fact, a situation similar to random assign-
ment, with respect to observed prognostic variables.
Based on the design, the comparisons of vaccinated
and unvaccinated groups are being made within
groups of similar individuals, who had the same
chance of receiving treatment. The adjustment was
based, however, on overt biases; that is to say, the
propensity score method does little or nothing to
address hidden biases due to unobserved or unre-
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corded differences between treated and control
individuals [47].
Fourth, although our study had the advantage of
having access to individual characteristics drawn from
the NHIS and detailed claim data, allowing us to iden-
tify a number of “overt” variables such as health status
and socioeconomic status and relate them to both vac-
cination and outpatient visits, our study was not able
to control hidden biases possibly caused by other
unobserved variables such as trafﬁc commute or acces-
sibility of health care. The goodness-of-ﬁt test of the
model (Hosmer–Lemeshow goodness-of-ﬁt test) was
6.03 with a P-value of 0.64, suggesting that the esti-
mate on vaccine effect with propensity score adjust-
ment would still be biased if these unobserved
variables had strong relationships with both vaccina-
tion and outpatient visits.
In conclusion, considering the effectiveness of the
vaccination on controlling the spread of the epidemic,
it is unfortunate that only 50.1% of the elderly aged
65 years or older received inﬂuenza vaccinations in
2002. This was a especially low ﬁgure, considering
that the vaccination was being provided free of charge.
In light of our ﬁndings, we believe more could be done
to increase the vaccination rate in people aged 76 years
or older, illiterate elderly people, and uncoupled eld-
erly patients, as there may be social barriers to access
to the public health system. Furthermore, our ﬁnding
that people with preepidemic outpatient visits were
more likely to be vaccinated possibly indicates that
either the physician recommended vaccinations [34] to
frequent care-users or that these patients were more
likely to take defensive measures (perceptions of risk
or health needs [30–32]). Based on these reports, we
should try to provide more education or information
on inﬂuenza vaccination, particularly its effect on pre-
venting outbreaks of epidemic, directly to those who
do not make much use of outpatient care and those
who do not think they need the vaccine.
Source of ﬁnancial support: This research used NHIS and
NHI data collected by the Bureau of Health Promotion and
National Health Research Institutes. No additional external
ﬁnancial support was granted. 
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